Pharmeasy has come up with rights issue. The issue is of convertible preference shares at 96.80. As it will convert to 20 shares, the shares will at ₹4.84.
I hold some shares at ₹20! So, it makes sense for me to invest in these.
Subscribe To Our Free Newsletter |